JPRN-jRCT1080220086未知4 期
Post marketing study of sivelestat sodium hydrate for acute lung injury associated with systemic inflammatory response syndrome
ONO PHARMACEUTICAL CO.,LTD.0 个研究点开始时间: 2005年9月12日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Male and female patients with ALI associated with SIRS aged over 18 years old are included.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Sivelestat Sodium Hydrate Treatment for Patients with Kawasaki Disease refractory to initial intravenous immunoglobulin therapyKawasaki DiseaseJPRN-UMIN000013018Department of Pediatrics, Chiba University Hospital45
已完成
3 期
Preventive effect of Sivelestat Na Hydrate on postoperative acute exacerbation of idiopathic interstitial pneumonia in the patient with lung canceridiopathic interstitial pneumonia (IIP)JPRN-UMIN000021109Japanese Northern East Area Thoracic Surgery Study Group (JNETS)120
已完成
2 期
Efficacy of sivelestat sodium administration in perioperative care of abdominal aortic aneurysm with pulmonary function disorderabdominal aortic aneurysmJPRN-UMIN000000650Keio University, School of Medicine Department of Surgery40
已完成
1 期
A pilot study of Elaspol (Sivelestat Sodium) for neuromyelitis opticaneuromyelitis opticaJPRN-UMIN000010094Tohoku University Hospital10
已完成
4 期
Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in JapanSystemic Inflammatory Response SyndromeAcute Lung InjuryNCT00219375Ono Pharmaceutical Co. Ltd649